- Home
- HAIN vs VXRT Comparison
HAIN vs VXRT Comparison
Compare HAIN & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAIN
- VXRT
- Stock Information
- Founded
- HAIN 1993
- VXRT N/A
- Country
- HAIN United States
- VXRT United States
- Employees
- HAIN N/A
- VXRT N/A
- Industry
- HAIN Packaged Foods
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HAIN Consumer Staples
- VXRT Health Care
- Exchange
- HAIN Nasdaq
- VXRT Nasdaq
- Market Cap
- HAIN 146.2M
- VXRT 119.0M
- IPO Year
- HAIN 1993
- VXRT N/A
- Fundamental
- Price
- HAIN $1.66
- VXRT $0.43
- Analyst Decision
- HAIN Hold
- VXRT Strong Buy
- Analyst Count
- HAIN 9
- VXRT 2
- Target Price
- HAIN $3.91
- VXRT $3.00
- AVG Volume (30 Days)
- HAIN 1.5M
- VXRT 9.6M
- Earning Date
- HAIN 08-26-2025
- VXRT 08-07-2025
- Dividend Yield
- HAIN N/A
- VXRT N/A
- EPS Growth
- HAIN N/A
- VXRT N/A
- EPS
- HAIN N/A
- VXRT N/A
- Revenue
- HAIN $1,615,231,000.00
- VXRT $47,395,000.00
- Revenue This Year
- HAIN N/A
- VXRT N/A
- Revenue Next Year
- HAIN N/A
- VXRT N/A
- P/E Ratio
- HAIN N/A
- VXRT N/A
- Revenue Growth
- HAIN N/A
- VXRT 433.43
- 52 Week Low
- HAIN $1.30
- VXRT $0.29
- 52 Week High
- HAIN $9.43
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- HAIN 43.73
- VXRT 41.25
- Support Level
- HAIN $1.46
- VXRT $0.42
- Resistance Level
- HAIN $1.77
- VXRT $0.60
- Average True Range (ATR)
- HAIN 0.11
- VXRT 0.08
- MACD
- HAIN 0.03
- VXRT -0.02
- Stochastic Oscillator
- HAIN 59.68
- VXRT 2.78
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.